US FDA Making BsUFA III Regulatory Science Grants Available Early

Up to $1m per year per award is available for projects that address significant issues with biosimilar or interchangeable product development.

Beaker with US money
The biosimilar regulatory science research pilot program is intended to resemble the FDA program already created for generic drugs. • Source: Alamy

More from Biosimilars

More from Biosimilars & Generics